Page last updated: 2024-08-26

arsenic and Multiple Sclerosis, Relapsing-Remitting

arsenic has been researched along with Multiple Sclerosis, Relapsing-Remitting in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Aliomrani, M; Amini, M; Beh-Pajooh, A; Ghahremani, MH; Hasani Nourian, Y; Hosseini, R; Mohammadi, S; Sahraian, MA1
Akbari, M; Asadikaram, G; Ebrahimi, G; Juybari, KB; Karimi, A; Mirzamohammadi, S; Momeni Moghaddam, MA; Nematollahi, MH; Torkzadeh-Mahani, M1

Other Studies

2 other study(ies) available for arsenic and Multiple Sclerosis, Relapsing-Remitting

ArticleYear
Changes in DNA methylation in APOE and ACKR3 genes in multiple sclerosis patients and the relationship with their heavy metal blood levels.
    Neurotoxicology, 2021, Volume: 87

    Topics: Adult; Apolipoproteins E; Arsenic; Cadmium; Case-Control Studies; DNA Methylation; Female; Genes; Humans; Male; Metals, Heavy; Multiple Sclerosis, Relapsing-Remitting; Real-Time Polymerase Chain Reaction; Receptors, CXCR

2021
Evaluation of serum arsenic and its effects on antioxidant alterations in relapsing-remitting multiple sclerosis patients.
    Multiple sclerosis and related disorders, 2018, Volume: 19

    Topics: Adult; Arsenic; Case-Control Studies; Female; Humans; Lactic Acid; Male; Malondialdehyde; Middle Aged; Multiple Sclerosis, Relapsing-Remitting; Oxidative Stress; Reactive Oxygen Species

2018